-
1
-
-
33749031535
-
The many facets of the Wilms' tumour gene, WT1
-
Hohenstein P, Hastie ND. The many facets of the Wilms' tumour gene, WT1. Hum Mol Genet. 2006;15:R196-R201.
-
(2006)
Hum Mol Genet.
, vol.15
-
-
Hohenstein, P.1
Hastie, N.D.2
-
2
-
-
9244237089
-
Growth inhibition of human leukemic cells by WT1 (Wilms tumor gene) antisense oligodeoxynucleotides: Implications for the involvement of WT1 in leukemogenesis
-
Yamagami T, Sugiyama H, Inoue K, et al. Growth inhibition of human leukemic cells by WT1 (Wilms tumor gene) antisense oligodeoxynucleotides: implications for the involvement of WT1 in leukemogenesis. Blood. 1996;87:2878-2884.
-
(1996)
Blood.
, vol.87
, pp. 2878-2884
-
-
Yamagami, T.1
Sugiyama, H.2
Inoue, K.3
-
3
-
-
0032522925
-
Wilms' tumor gene (WT1) competes with differentiation-inducing signal in hematopoietic progenitor cells
-
Inoue K, Tamaki H, Ogawa H, et al. Wilms' tumor gene (WT1) competes with differentiation-inducing signal in hematopoietic progenitor cells. Blood. 1998;91:2969-2976.
-
(1998)
Blood.
, vol.91
, pp. 2969-2976
-
-
Inoue, K.1
Tamaki, H.2
Ogawa, H.3
-
4
-
-
0032944068
-
Constitutive expression of the Wilms' tumor gene WT1 inhibits the differentiation of myeloid progenitor cells but promotes their proliferation in response to granulocyte-colony stimulating factor (G-CSF)
-
Tsuboi A, Oka Y, Ogawa H, et al. Constitutive expression of the Wilms' tumor gene WT1 inhibits the differentiation of myeloid progenitor cells but promotes their proliferation in response to granulocyte-colony stimulating factor (G-CSF). Leuk Res. 1999;23:499-505.
-
(1999)
Leuk Res.
, vol.23
, pp. 499-505
-
-
Tsuboi, A.1
Oka, Y.2
Ogawa, H.3
-
5
-
-
0025099787
-
Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus
-
Call KM, Glaser T, Ito CY, et al. Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus. Cell. 1990;60:509-520.
-
(1990)
Cell.
, vol.60
, pp. 509-520
-
-
Call, K.M.1
Glaser, T.2
Ito, C.Y.3
-
6
-
-
0025098654
-
Homozygous deletion in Wilms tumours of a zinc-finger gene identified by chromosome jumping
-
Gessler M, Poustka A, Cavenee W, et al. Homozygous deletion in Wilms tumours of a zinc-finger gene identified by chromosome jumping. Nature. 1990;343:774-778.
-
(1990)
Nature.
, vol.343
, pp. 774-778
-
-
Gessler, M.1
Poustka, A.2
Cavenee, W.3
-
7
-
-
77952566271
-
WT1 (Wilms' tumor gene 1): Biology and cancer immunotherapy
-
Sugiyama H. WT1 (Wilms' tumor gene 1): biology and cancer immunotherapy. Jpn J Clin Oncol. 2010;40:377-387.
-
(2010)
Jpn J Clin Oncol.
, vol.40
, pp. 377-387
-
-
Sugiyama, H.1
-
8
-
-
0034112824
-
Human cytotoxic Tlymphocyte responses specific for peptides of the wild-type Wilms' tumor gene (WT1) product
-
Oka Y, Elisseeva OA, Tsuboi A, et al. Human cytotoxic Tlymphocyte responses specific for peptides of the wild-type Wilms' tumor gene (WT1) product. Immunogenetics. 2000;51: 99-107.
-
(2000)
Immunogenetics.
, vol.51
, pp. 99-107
-
-
Oka, Y.1
Elisseeva, O.A.2
Tsuboi, A.3
-
9
-
-
0033966369
-
HLA class I-restricted lysis of leukemia cells by a CD8(+) cytotoxic T-lymphocyte clone specific for WT1 peptide
-
Ohminami H, Yasukawa M, Fujita S. HLA class I-restricted lysis of leukemia cells by a CD8(+) cytotoxic T-lymphocyte clone specific for WT1 peptide. Blood. 2000;95:286-293.
-
(2000)
Blood.
, vol.95
, pp. 286-293
-
-
Ohminami, H.1
Yasukawa, M.2
Fujita, S.3
-
10
-
-
4644289323
-
Induction of WT1 (Wilms' tumor gene)-specific cytotoxic T lymphocytes by WT1 peptide vaccine and the resultant cancer regression
-
Oka Y, Tsuboi A, Taguchi T, et al. Induction of WT1 (Wilms' tumor gene)-specific cytotoxic T lymphocytes by WT1 peptide vaccine and the resultant cancer regression. Proc Natl Acad Sci USA. 2004;101:13885-13890.
-
(2004)
Proc Natl Acad Sci USA.
, vol.101
, pp. 13885-13890
-
-
Oka, Y.1
Tsuboi, A.2
Taguchi, T.3
-
11
-
-
84861999235
-
Long-term WT1 peptide vaccination for patients with acute myeloid leukemia with minimal residual disease
-
Tsuboi A, Oka Y, Kyo T, et al. Long-term WT1 peptide vaccination for patients with acute myeloid leukemia with minimal residual disease. Leukemia. 2011;26:1410-1413.
-
(2011)
Leukemia.
, vol.26
, pp. 1410-1413
-
-
Tsuboi, A.1
Oka, Y.2
Kyo, T.3
-
12
-
-
33745686444
-
A phase I/II trial of a WT1 (Wilms' tumor gene) peptide vaccine in patients with solid malignancy: Safety assessment based on the phase i data
-
Morita S, Oka Y, Tsuboi A, et al. A phase I/II trial of a WT1 (Wilms' tumor gene) peptide vaccine in patients with solid malignancy: safety assessment based on the phase I data. Jpn J Clin Oncol. 2006;36:231-236.
-
(2006)
Jpn J Clin Oncol.
, vol.36
, pp. 231-236
-
-
Morita, S.1
Oka, Y.2
Tsuboi, A.3
-
13
-
-
69049089548
-
The prioritization of cancer antigens: A national cancer institute pilot project for the acceleration of translational research
-
Cheever MA, Allison JP, Ferris AS, et al. The prioritization of cancer antigens: a national cancer institute pilot project for the acceleration of translational research. Clin Cancer Res. 2009;15:5323-5337.
-
(2009)
Clin Cancer Res.
, vol.15
, pp. 5323-5337
-
-
Cheever, M.A.1
Allison, J.P.2
Ferris, A.S.3
-
14
-
-
80051611504
-
Novel adoptive T-cell immunotherapy using a WT1-specific TCR vector encoding silencers for endogenous TCRs shows marked antileukemia reactivity and safety
-
Ochi T, Fujiwara H, Okamoto S, et al. Novel adoptive T-cell immunotherapy using a WT1-specific TCR vector encoding silencers for endogenous TCRs shows marked antileukemia reactivity and safety. Blood. 2011;118:1495-1503.
-
(2011)
Blood.
, vol.118
, pp. 1495-1503
-
-
Ochi, T.1
Fujiwara, H.2
Okamoto, S.3
-
15
-
-
27644566777
-
Elimination of human leukemia cells in NOD/SCID mice by WT1-TCR gene-transduced human T cells
-
Xue SA, Gao L, Hart D, et al. Elimination of human leukemia cells in NOD/SCID mice by WT1-TCR gene-transduced human T cells. Blood. 2005;106:3062-3067.
-
(2005)
Blood.
, vol.106
, pp. 3062-3067
-
-
Xue, S.A.1
Gao, L.2
Hart, D.3
-
16
-
-
79952187823
-
T cells targeting carcinoembryonic antigen can mediate regression of metastatic colorectal cancer but induce severe transient colitis
-
Parkhurst MR, Yang JC, Langan RC, et al. T cells targeting carcinoembryonic antigen can mediate regression of metastatic colorectal cancer but induce severe transient colitis. Mol Ther. 2011;19:620-626.
-
(2011)
Mol Ther.
, vol.19
, pp. 620-626
-
-
Parkhurst, M.R.1
Yang, J.C.2
Langan, R.C.3
-
17
-
-
78650410673
-
Development of human anti-murine T-cell receptor antibodies in both responding and nonresponding patients enrolled in TCR gene therapy trials
-
Davis JL, Theoret MR, Zheng Z, et al. Development of human anti-murine T-cell receptor antibodies in both responding and nonresponding patients enrolled in TCR gene therapy trials. Clin Cancer Res. 2010;16:5852-5861.
-
(2010)
Clin Cancer Res.
, vol.16
, pp. 5852-5861
-
-
Davis, J.L.1
Theoret, M.R.2
Zheng, Z.3
-
18
-
-
84855533370
-
Cytotoxic CD4 T cells in antiviral immunity
-
Marshall NB, Swain SL. Cytotoxic CD4 T cells in antiviral immunity. J Biomed Biotechnol. 2011;2011:954602.
-
(2011)
J Biomed Biotechnol.
, vol.2011
, pp. 954602
-
-
Marshall, N.B.1
Swain, S.L.2
-
19
-
-
0037456367
-
CD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytes
-
Janssen EM, Lemmens EE, Wolfe T, et al. CD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytes. Nature. 2003;421:852-856.
-
(2003)
Nature.
, vol.421
, pp. 852-856
-
-
Janssen, E.M.1
Lemmens, E.E.2
Wolfe, T.3
-
20
-
-
45549099784
-
Treatment of metastatic melanoma with autologous CD4+ T cells against NY-ESO-1
-
Hunder NN, Wallen H, Cao J, et al. Treatment of metastatic melanoma with autologous CD4+ T cells against NY-ESO-1. N Engl J Med. 2008;358:2698-2703.
-
(2008)
N Engl J Med.
, vol.358
, pp. 2698-2703
-
-
Hunder, N.N.1
Wallen, H.2
Cao, J.3
-
21
-
-
77949522803
-
Tumor-reactive CD4(+) T cells develop cytotoxic activity and eradicate large established melanoma after transfer into lymphopenic hosts
-
Quezada SA, Simpson TR, Peggs KS, et al. Tumor-reactive CD4(+) T cells develop cytotoxic activity and eradicate large established melanoma after transfer into lymphopenic hosts. J Exp Med. 2010;207:637-650.
-
(2010)
J Exp Med.
, vol.207
, pp. 637-650
-
-
Quezada, S.A.1
Simpson, T.R.2
Peggs, K.S.3
-
22
-
-
34247174293
-
Identification and characterization of a WT1 (Wilms Tumor Gene) protein-derived HLA-DRB1*0405-restricted 16-mer helper peptide that promotes the induction and activation of WT1-specific cytotoxic T lymphocytes
-
Fujiki F, Oka Y, Tsuboi A, et al. Identification and characterization of a WT1 (Wilms Tumor Gene) protein-derived HLA-DRB1*0405-restricted 16-mer helper peptide that promotes the induction and activation of WT1-specific cytotoxic T lymphocytes. J Immunother. 2007;30:282-293.
-
(2007)
J Immunother.
, vol.30
, pp. 282-293
-
-
Fujiki, F.1
Oka, Y.2
Tsuboi, A.3
-
23
-
-
59449087616
-
A WT1 protein-derived, naturally processed 16-mer peptide, WT1(332), is a promiscuous helper peptide for induction of WT1-specific Th1-type CD4(+) T cells
-
Fujiki F, Oka Y, Kawakatsu M, et al. A WT1 protein-derived, naturally processed 16-mer peptide, WT1(332), is a promiscuous helper peptide for induction of WT1-specific Th1-type CD4(+) T cells. Microbiol Immunol. 2008;52:591-600.
-
(2008)
Microbiol Immunol.
, vol.52
, pp. 591-600
-
-
Fujiki, F.1
Oka, Y.2
Kawakatsu, M.3
-
24
-
-
23744460167
-
Direct recognition and lysis of leukemia cells by WT1-specific CD4+ T lymphocytes in an HLA class II-restricted manner
-
Guo Y, Niiya H, Azuma T, et al. Direct recognition and lysis of leukemia cells by WT1-specific CD4+ T lymphocytes in an HLA class II-restricted manner. Blood. 2005;106:1415-1418.
-
(2005)
Blood.
, vol.106
, pp. 1415-1418
-
-
Guo, Y.1
Niiya, H.2
Azuma, T.3
-
25
-
-
77955064368
-
A clear correlation between WT1-specific Th response and clinical response in WT1 CTL epitope vaccination
-
Fujiki F, Oka Y, Kawakatsu M, et al. A clear correlation between WT1-specific Th response and clinical response in WT1 CTL epitope vaccination. Anticancer Res. 2010;30:2247-2254.
-
(2010)
Anticancer Res.
, vol.30
, pp. 2247-2254
-
-
Fujiki, F.1
Oka, Y.2
Kawakatsu, M.3
-
26
-
-
0026513471
-
Co-expression of human T cell receptor chains with mouse CD3 on the cell surface of a mouse T cell hybridoma
-
ZumLa A, Marguerie C, So A, et al. Co-expression of human T cell receptor chains with mouse CD3 on the cell surface of a mouse T cell hybridoma. J Immunol Methods. 1992;149:69-76.
-
(1992)
J Immunol Methods.
, vol.149
, pp. 69-76
-
-
Zumla, A.1
Marguerie, C.2
So, A.3
-
27
-
-
0028006324
-
Establishment of a new cell line with the characteristics of a multipotential progenitor from a patient with chronic myelogenous leukemia in early erythroblastic crisis
-
Furukawa T, Koike T, Ying W, et al. Establishment of a new cell line with the characteristics of a multipotential progenitor from a patient with chronic myelogenous leukemia in early erythroblastic crisis. Leukemia. 1994;8:171-180.
-
(1994)
Leukemia.
, vol.8
, pp. 171-180
-
-
Furukawa, T.1
Koike, T.2
Ying, W.3
-
28
-
-
0036566202
-
Humoral immune responses against Wilms tumor gene WT1 product in patients with hematopoietic malignancies
-
Elisseeva OA, Oka Y, Tsuboi A, et al. Humoral immune responses against Wilms tumor gene WT1 product in patients with hematopoietic malignancies. Blood. 2002;99:3272-3279.
-
(2002)
Blood.
, vol.99
, pp. 3272-3279
-
-
Elisseeva, O.A.1
Oka, Y.2
Tsuboi, A.3
-
29
-
-
67449088945
-
WT1 IgG antibody for early detection of nonsmall cell lung cancer and as its prognostic factor
-
Oji Y, Kitamura Y, Kamino E, et al. WT1 IgG antibody for early detection of nonsmall cell lung cancer and as its prognostic factor. Int J Cancer. 2009;125:381-387.
-
(2009)
Int J Cancer.
, vol.125
, pp. 381-387
-
-
Oji, Y.1
Kitamura, Y.2
Kamino, E.3
-
30
-
-
0033743984
-
Cell death induction by CTL: Perforin/granzyme B system dominantly acts for cell death induction in human hepatocellular carcinoma cells
-
Hayashida M, Kawano H, Nakano T, et al. Cell death induction by CTL: perforin/granzyme B system dominantly acts for cell death induction in human hepatocellular carcinoma cells. Proc Soc Exp Biol Med. 2000;225:143-150.
-
(2000)
Proc Soc Exp Biol Med.
, vol.225
, pp. 143-150
-
-
Hayashida, M.1
Kawano, H.2
Nakano, T.3
-
31
-
-
27144557584
-
A live-cell assay to detect antigen-specific CD4+ T cells with diverse cytokine profiles
-
Chattopadhyay PK, Yu J, Roederer M. A live-cell assay to detect antigen-specific CD4+ T cells with diverse cytokine profiles. Nat Med. 2005;11:1113-1117.
-
(2005)
Nat Med.
, vol.11
, pp. 1113-1117
-
-
Chattopadhyay, P.K.1
Yu, J.2
Roederer, M.3
-
32
-
-
77953457564
-
Both CD4 and CD8 T cells mediate equally effective in vivo tumor treatment when engineered with a highly avid TCR targeting tyrosinase
-
Frankel TL, Burns WR, Peng PD, et al. Both CD4 and CD8 T cells mediate equally effective in vivo tumor treatment when engineered with a highly avid TCR targeting tyrosinase. J Immunol. 2010;184:5988-5998.
-
(2010)
J Immunol.
, vol.184
, pp. 5988-5998
-
-
Frankel, T.L.1
Burns, W.R.2
Peng, P.D.3
-
33
-
-
22144447521
-
Generation of tumor-specific, HLA class I-restricted human Th1 and Tc1 cells by cell engineering with tumor peptide-specific T-cell receptor genes
-
Tsuji T, Yasukawa M, Matsuzaki J, et al. Generation of tumor-specific, HLA class I-restricted human Th1 and Tc1 cells by cell engineering with tumor peptide-specific T-cell receptor genes. Blood. 2005;106:470-476.
-
(2005)
Blood.
, vol.106
, pp. 470-476
-
-
Tsuji, T.1
Yasukawa, M.2
Matsuzaki, J.3
-
34
-
-
77955270629
-
MHC-I-restricted melanoma antigen specific TCR-engineered human CD4+ T cells exhibit multifunctional effector and helper responses, in vitro
-
Ray S, Chhabra A, Chakraborty NG, et al. MHC-I-restricted melanoma antigen specific TCR-engineered human CD4+ T cells exhibit multifunctional effector and helper responses, in vitro. Clin Immunol. 2010;136:338-347.
-
(2010)
Clin Immunol.
, vol.136
, pp. 338-347
-
-
Ray, S.1
Chhabra, A.2
Chakraborty, N.G.3
-
35
-
-
78649878384
-
Transplantation of mouse HSCs genetically modified to express a CD4-restricted TCR results in long-term immunity that destroys tumors and initiates spontaneous autoimmunity
-
Ha SP, Klemen ND, Kinnebrew GH, et al. Transplantation of mouse HSCs genetically modified to express a CD4-restricted TCR results in long-term immunity that destroys tumors and initiates spontaneous autoimmunity. J Clin Invest. 2010;120: 4273-4288.
-
(2010)
J Clin Invest.
, vol.120
, pp. 4273-4288
-
-
Ha, S.P.1
Klemen, N.D.2
Kinnebrew, G.H.3
-
36
-
-
33747872062
-
Transduction of an HLADP4- restricted NY-ESO-1-specific TCR into primary human CD4+ lymphocytes
-
Zhao Y, Zheng Z, Khong HT, et al. Transduction of an HLADP4- restricted NY-ESO-1-specific TCR into primary human CD4+ lymphocytes. J Immunother. 2006;29:398-406.
-
(2006)
J Immunother.
, vol.29
, pp. 398-406
-
-
Zhao, Y.1
Zheng, Z.2
Khong, H.T.3
-
37
-
-
80052342180
-
Generating HPV specific T helper cells for the treatment of HPV induced malignancies using TCR gene transfer
-
Scholten KB, Turksma AW, Ruizendaal JJ, et al. Generating HPV specific T helper cells for the treatment of HPV induced malignancies using TCR gene transfer. J Transl Med. 2011;9:147.
-
(2011)
J Transl Med.
, vol.9
, pp. 147
-
-
Scholten, K.B.1
Turksma, A.W.2
Ruizendaal, J.J.3
-
38
-
-
0032473562
-
Specific T helper cell requirement for optimal induction of cytotoxic T lymphocytes against major histocompatibility complex class II negative tumors
-
Ossendorp F, Mengedé E, Camps M, et al. Specific T helper cell requirement for optimal induction of cytotoxic T lymphocytes against major histocompatibility complex class II negative tumors. J Exp Med. 1998;187:693-702.
-
(1998)
J Exp Med.
, vol.187
, pp. 693-702
-
-
Ossendorp, F.1
Mengedé, E.2
Camps, M.3
-
39
-
-
84862776631
-
Preexisting influenzaspecific CD4+ T cells correlate with disease protection against influenza challenge in humans
-
Wilkinson TM, Li CK, Chui CS, et al. Preexisting influenzaspecific CD4+ T cells correlate with disease protection against influenza challenge in humans. Nat Med. 2012;18: 274-280.
-
(2012)
Nat Med.
, vol.18
, pp. 274-280
-
-
Wilkinson, T.M.1
Li, C.K.2
Chui, C.S.3
-
40
-
-
39649115582
-
The transcriptome of human cytotoxic T cells: Similarities and disparities among allostimulated CD4(+) CTL, CD8(+) CTL and NK cells
-
Hidalgo LG, Einecke G, Allanach K, et al. The transcriptome of human cytotoxic T cells: similarities and disparities among allostimulated CD4(+) CTL, CD8(+) CTL and NK cells. Am J Transplant. 2008;8:627-636.
-
(2008)
Am J Transplant.
, vol.8
, pp. 627-636
-
-
Hidalgo, L.G.1
Einecke, G.2
Allanach, K.3
-
41
-
-
77950858633
-
Cytolytic CD4 cells: Direct mediators in infectious disease and malignancy
-
Brown DM. Cytolytic CD4 cells: Direct mediators in infectious disease and malignancy. Cell Immunol. 2010;262: 89-95.
-
(2010)
Cell Immunol.
, vol.262
, pp. 89-95
-
-
Brown, D.M.1
-
42
-
-
0344406265
-
Association of ovarian tumor epithelium coexpressing HLA-DR and CA-125 antigens with tumor infiltrating cytotoxic T lymphocytes
-
Matsushita N, Ghazizadeh M, Konishi H, et al. Association of ovarian tumor epithelium coexpressing HLA-DR and CA-125 antigens with tumor infiltrating cytotoxic T lymphocytes. J Nihon Med Sch. 2003;70:40-44.
-
(2003)
J Nihon Med Sch.
, vol.70
, pp. 40-44
-
-
Matsushita, N.1
Ghazizadeh, M.2
Konishi, H.3
-
43
-
-
0242624621
-
Targeted therapy of solid malignancies via HLA class II antigens: A new biotherapeutic approach
-
Altomonte M, Fonsatti E, Visintin A, et al. Targeted therapy of solid malignancies via HLA class II antigens: a new biotherapeutic approach? Oncogene. 2003;22:6564-6569.
-
(2003)
Oncogene
, vol.22
, pp. 6564-6569
-
-
Altomonte, M.1
Fonsatti, E.2
Visintin, A.3
-
44
-
-
2542429298
-
Loss of MHC class II gene and protein expression in diffuse large B-cell lymphoma is related to decreased tumor immunosurveillance and poor patient survival regardless of other prognostic factors: A follow-up study from the Leukemia and LymphomaMolecular Profiling Project
-
Rimsza LM, Roberts RA, Miller TP, et al. Loss of MHC class II gene and protein expression in diffuse large B-cell lymphoma is related to decreased tumor immunosurveillance and poor patient survival regardless of other prognostic factors: a follow-up study from the Leukemia and LymphomaMolecular Profiling Project. Blood. 2004;103:4251-4258.
-
(2004)
Blood.
, vol.103
, pp. 4251-4258
-
-
Rimsza, L.M.1
Roberts, R.A.2
Miller, T.P.3
-
45
-
-
84860417122
-
Human alloreactive CD4+ T cells as strong mediators of anti-tumor immunity in NOD/scid mice engrafted with human acute lymphoblastic leukemia
-
Stevanović S, Griffioen M, Nijmeijer BA, et al. Human alloreactive CD4+ T cells as strong mediators of anti-tumor immunity in NOD/scid mice engrafted with human acute lymphoblastic leukemia. Leukemia. 2012;26:312-322.
-
(2012)
Leukemia.
, vol.26
, pp. 312-322
-
-
Stevanović, S.1
Griffioen, M.2
Nijmeijer, B.A.3
-
46
-
-
0242708508
-
Strong HLA-DR expression in microsatellite stable carcinomas of the large bowel is associated with good prognosis
-
Loøvig T, Andersen SN, Thorstensen L, et al. Strong HLA-DR expression in microsatellite stable carcinomas of the large bowel is associated with good prognosis. Br J Cancer. 2002; 87:756-762.
-
(2002)
Br J Cancer.
, vol.87
, pp. 756-762
-
-
Loøvig, T.1
Andersen, S.N.2
Thorstensen, L.3
-
47
-
-
0037428757
-
On the biological relevance of MHC class II and B7 expression by tumour cells in melanoma metastases
-
Bernsen MR, Hakansson L, Gustafsson B, et al. On the biological relevance of MHC class II and B7 expression by tumour cells in melanoma metastases. Br J Cancer. 2003;88: 424-431.
-
(2003)
Br J Cancer.
, vol.88
, pp. 424-431
-
-
Bernsen, M.R.1
Hakansson, L.2
Gustafsson, B.3
-
48
-
-
84861231609
-
Tumor-specific CD4+ melanoma tumor-infiltrating lymphocytes
-
Friedman KM, Prieto PA, Devillier LE, et al. Tumor-specific CD4+ melanoma tumor-infiltrating lymphocytes. J Immunother. 2012;35:400-408.
-
(2012)
J Immunother.
, vol.35
, pp. 400-408
-
-
Friedman, K.M.1
Prieto, P.A.2
Devillier, L.E.3
|